Feasibility of alcohol screening and brief intervention in primary health care in Kazakhstan: a pilot cluster randomized trial

Feasibility of alcohol screening and brief intervention in primary health care in Kazakhstan: a pilot cluster randomized trial - ASBIKaz

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00015882

Enrollment

4000

Registered

2018-12-17

Start date

2019-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

risky drinking F10.1

Interventions

Group 1: In the interventional arm, female patients screened with an AUDIT-C score of 3 or lower and male patients screened with an AUDIT-C score of 4 or lower will receive a short feedback according

Eligibility

Sex/Gender

All

Age

18 Years to 69 Years

Inclusion criteria

Inclusion criteria: Ability to follow the study procedures and provision of signed informed consent

Exclusion criteria

Exclusion criteria: ever diagnosed alcohol dependency (lifetime) according to ICD 10

Design outcomes

Primary

Measure	Time frame
Feasibilty and acceptance of ASBI in routine primary health care in Kazakhstan measured on the basis of (1) rates of eligibility, participation and retention at three months follow-up and (2) quantitative and qualitative data on the patient and provider perspective	—

Secondary

Measure	Time frame
(1) Reach: (1a) Proportion of consulting adult patients intervened at baseline; Numerator: Total number of patients screened and advised; Denominator: Total number of patients screened positive (1b) Proportion of patients screened at baseline; Numerator: Total number of completed screens; Denominator: Total number of all patients eligible for screening (2) Effectiveness: Change in AUDIT-C score between baseline and follow-up among patients with risky, hazardous or harmful drinking (3) Adoption. (3a) Proportion of staff invited that participated; Numerator: Total number of participating physicians; Denominator: Total number of primary care physicians invited (3b) Description and representativeness of staff who delivered the screening and advice (PHC provider level) (4) Implementation: (4a) Quality and consistency of the delivery of ASBI given (PHC provider level; patient level) measured by quantitative interviews and open questions (4b) Implementation determinants (barriers, facilitators) of ASBI delivery (PHC provider, Patient level) collected by quantitative interviews and open questions questions as well as focus groups (4c) Cost of intervention (defined by time): Average time for screening and brief intervention per patient (5) Maintenance: Potential extent to which the intervention package becomes institutionalized (PHC provider level; patient level) collected by quantitative interviews and open questions as well as focus groups	—

Measure

Time frame

(1) Reach: (1a) Proportion of consulting adult patients intervened at baseline; Numerator: Total number of patients screened and advised; Denominator: Total number of patients screened positive (1b) Proportion of patients screened at baseline; Numerator: Total number of completed screens; Denominator: Total number of all patients eligible for screening (2) Effectiveness: Change in AUDIT-C score between baseline and follow-up among patients with risky, hazardous or harmful drinking (3) Adoption. (3a) Proportion of staff invited that participated; Numerator: Total number of participating physicians; Denominator: Total number of primary care physicians invited (3b) Description and representativeness of staff who delivered the screening and advice (PHC provider level) (4) Implementation: (4a) Quality and consistency of the delivery of ASBI given (PHC provider level; patient level) measured by quantitative interviews and open questions (4b) Implementation determinants (barriers, facilitators) of ASBI delivery (PHC provider, Patient level) collected by quantitative interviews and open questions questions as well as focus groups (4c) Cost of intervention (defined by time): Average time for screening and brief intervention per patient (5) Maintenance: Potential extent to which the intervention package becomes institutionalized (PHC provider level; patient level) collected by quantitative interviews and open questions as well as focus groups

—

Countries

Kazakhstan

Contacts

Public ContactOleg Yussopov

Monitoring Center on Alcohol and Drugs

mcadkz@gmail.com+7 (701) 883-78-25

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 28, 2026